The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Stadler, Walter M.
One or more keywords matched the following properties of Stadler, Walter M.
PropertyValue
keywords Clinical Trials as Topic
overview Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Concept Clinical Competence
Concept Clinical Protocols
Concept Clinical Trials, Phase I as Topic
Concept Randomized Controlled Trials as Topic
Concept Clinical Trials, Phase II as Topic
Concept Decision Support Systems, Clinical
Concept Compassionate Use Trials
Concept Early Termination of Clinical Trials
Concept Clinical Trials, Phase III as Topic
Academic Article Study of cohort-specific consent and patient control in phase I cancer trials.
Academic Article Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Academic Article Metastatic bladder cancer: advances in treatment.
Academic Article Development of target-based antineoplastic agents.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Academic Article Gemcitabine doublets in advanced urothelial cancer.
Academic Article Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Academic Article Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Academic Article New trial designs to assess antitumor and antiproliferative agents in prostate cancer.
Academic Article Angiogenesis inhibitors.
Academic Article Angiogenesis inhibitors in genitourinary cancers.
Academic Article Clinical trial designs for cytostatic agents.
Academic Article Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Academic Article Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Academic Article Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
Academic Article Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Academic Article Cytotoxic chemotherapy for metastatic renal cell carcinoma.
Academic Article Development of growth inhibitory agents in urological and other malignancies.
Academic Article The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
Academic Article Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Academic Article Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.
Academic Article Sorafenib.
Academic Article New targets, therapies, and toxicities: lessons to be learned.
Academic Article Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America.
Academic Article Effective therapy for metastatic renal cancer, whither to now.
Academic Article Recommended changes to oncology clinical trial design: revolution or evolution?
Academic Article Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
Academic Article Developing drugs that do not cause tumor regression.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article Randomized phase II trials: a long-term investment with promising returns.
Academic Article Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Academic Article The cure of bladder cancer: the need for multidisciplinary efforts.
Academic Article Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Academic Article Pazopanib in renal cell carcinoma.
Academic Article A trial postmortem: challenges in conducting a randomized, double-blind, phase 2 study in men with castration-resistant prostate cancer.
Academic Article Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Academic Article Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article Other paradigms: randomized discontinuation trial design.
Academic Article Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.
Academic Article A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
Academic Article Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Challenges with continuity clinic and core faculty accreditation requirements.
Academic Article Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
Academic Article Predictive markers in advanced renal cell carcinoma.
Academic Article The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
Academic Article Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
Academic Article Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
Academic Article Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?
Academic Article Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
Academic Article Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Academic Article Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Academic Article The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.
Academic Article Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
Academic Article Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
Academic Article Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Academic Article Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Academic Article Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Academic Article Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Academic Article Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Academic Article Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Academic Article The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Academic Article Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.
Academic Article Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial.
Academic Article Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.
Academic Article Efficacy and Safety of Telaglenastat Plus Cabozantinib vs Placebo Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma: The CANTATA Randomized Clinical Trial.
Concept Clinical Decision-Making
Academic Article Enrollment Barriers for Molecular Targeted Trials.
Academic Article Optimizing the doses of cancer drugs after usual dose finding.
Search Criteria
  • Clinical
  • Trials